Certain cells from a mother persist in their children’s bodies and can provoke an immune response in which the child’s body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org). The findings are important not only in seeking the cause and treatments of this disease, but also in understanding an entire class of autoimmune disorders.
Juvenile dermatomyositis (der-mat-o-my-o-SITE-us), or JDM, is a rare muscle-damaging condition that causes a child’s immune system to attack the body, as if it were an invading life form. Muscles deteriorate and the child becomes weak and fragile. There is no cure for JDM. Current treatments include medication, physical therapy and added nutrition.
“The key aspect of our study suggests a mechanism for the disease, and deepens our understanding of autoimmune disorders in general,” says pediatrician and lead investigator Ann Reed, M.D. “And because we studied a larger population of JDM patients and control groups than has ever been studied, we can feel confident in our results.”
Researchers have known for years that fetal cells can be found in women several years after giving birth. They have thought these may contribute to the development of autoimmune diseases in women during and after their childbearing years. In the current study, the Mayo Clinic group looked at the opposite situation: persistence of maternal cells in children.
In the Mayo Clinic study, 83 percent of JDM patients had cells from their mother. This compares to 23 percent of their unaffected siblings who had maternal cells, and 17 percent of healthy children who had maternal cells in their blood. The presence of this maternal (also called “chimeric”) cell is strongly associated with a particular genetic makeup of the mother. Children with JDM may suffer organ failure in the same way transplant patients often do. Because of this resemblance to a type of organ rejection disease, the Mayo Clinic team investigated the idea that “non-self” or chemeric cells may play a role in initiating JDM.
The Mayo Clinic researchers discovered two new aspects of chimeric cells. First, they remain in the offspring after birth and are related to the HLA genes, and second, chimeric cells are not merely present in the children — but they are active, as shown by the attacks they mount against the child’s body.
JDM causes inflammation of the blood vessels under the muscle and skin. This results in muscle damage, as well as in tissue changes of skin over the eyelids, finger joints and knuckles. Symptoms appear gradually and include: muscle pain and tenderness; difficulty swallowing, which results in weight loss; irritability; fatigue; fever; rash around the eyelids, finger joints, knuckles, elbows, ankles or knees.
Diagnosis may involve blood tests to detect muscle enzymes and markers of inflammation; an electromyography (EMG) to assess nerve or muscle damage; muscle biopsy for examination; X-rays; and MRI. Current treatments include medications to reduce inflammation and skin rashes; physical and occupational therapy to improve muscle function; and nutritional support.
[Reed, A.M., McNallan, K., Wettstein, P., Vehe, R., and Ober, C. (2004). Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J. Immunol. 172, 5041-5046.]
Nitric oxide-scavenging hydrogel developed for rheumatoid arthritis treatment
06.06.2019 | Pohang University of Science & Technology (POSTECH)
Infants later diagnosed with autism follow adults’ gaze, but seldom initiate joint attention
24.05.2019 | Schwedischer Forschungsrat - The Swedish Research Council
Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.
Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...
Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.
The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...
Discovery by Brazilian and US researchers could change the classification of two species, which appear more akin to jellyfish than was thought.
The tube anemone Isarachnanthus nocturnus is only 15 cm long but has the largest mitochondrial genome of any animal sequenced to date, with 80,923 base pairs....
Researchers at Chalmers University of Technology, Sweden, have discovered a completely new way of capturing, amplifying and linking light to matter at the nanolevel. Using a tiny box, built from stacked atomically thin material, they have succeeded in creating a type of feedback loop in which light and matter become one. The discovery, which was recently published in Nature Nanotechnology, opens up new possibilities in the world of nanophotonics.
Photonics is concerned with various means of using light. Fibre-optic communication is an example of photonics, as is the technology behind photodetectors and...
Fraunhofer IZM is joining the EUROPRACTICE IC Service platform. Together, the partners are making fan-out wafer level packaging (FOWLP) for electronic devices available and affordable even in small batches – and thus of interest to research institutes, universities, and SMEs. Costs can be significantly reduced by up to ten customers implementing individual fan-out wafer level packaging for their ICs or other components on a multi-project wafer. The target group includes any organization that does not produce in large quantities, but requires prototypes.
Research always means trying things out and daring to do new things. Research institutes, universities, and SMEs do not produce in large batches, but rather...
29.04.2019 | Event News
17.04.2019 | Event News
15.04.2019 | Event News
14.06.2019 | Information Technology
14.06.2019 | Materials Sciences
14.06.2019 | Medical Engineering